Glenmark Pharmaceuticals consolidated net profit rises 6.99% in the September 2014 quarter

Sales rise 14.25% to Rs 1671.53 crore

Net profit of Glenmark Pharmaceuticals rose 6.99% to Rs 165.08 crore in the quarter ended September 2014 as against Rs 154.30 crore during the previous quarter ended September 2013. Sales rose 14.25% to Rs 1671.53 crore in the quarter ended September 2014 as against Rs 1463.01 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales1671.531463.01 14 OPM %20.0521.58 -PBDT285.16280.63 2 PBT220.16220.10 0 NP165.08154.30 7

Powered by Capital Market - Live News